HN2000000219A - Compuesto farmaceuticamente activos - Google Patents

Compuesto farmaceuticamente activos

Info

Publication number
HN2000000219A
HN2000000219A HN2000000219A HN2000000219A HN2000000219A HN 2000000219 A HN2000000219 A HN 2000000219A HN 2000000219 A HN2000000219 A HN 2000000219A HN 2000000219 A HN2000000219 A HN 2000000219A HN 2000000219 A HN2000000219 A HN 2000000219A
Authority
HN
Honduras
Prior art keywords
active compound
pharmaceutically active
invention refers
pharmaceutically
compound
Prior art date
Application number
HN2000000219A
Other languages
English (en)
Original Assignee
Inc Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inc Pfizer filed Critical Inc Pfizer
Priority to HN2000000219A priority Critical patent/HN2000000219A/es
Publication of HN2000000219A publication Critical patent/HN2000000219A/es

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTO FARMACEUTICAMENTE ACTIVOS
HN2000000219A 2000-09-28 2000-09-28 Compuesto farmaceuticamente activos HN2000000219A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2000000219A HN2000000219A (es) 2000-09-28 2000-09-28 Compuesto farmaceuticamente activos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2000000219A HN2000000219A (es) 2000-09-28 2000-09-28 Compuesto farmaceuticamente activos

Publications (1)

Publication Number Publication Date
HN2000000219A true HN2000000219A (es) 2001-04-16

Family

ID=53190381

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2000000219A HN2000000219A (es) 2000-09-28 2000-09-28 Compuesto farmaceuticamente activos

Country Status (1)

Country Link
HN (1) HN2000000219A (es)

Similar Documents

Publication Publication Date Title
HN2001000139A (es) Interleuquina 2 estabilizada
HN1999000066A (es) Formulaciones farmaceuticas
HN1999000089A (es) Formulaciones de ziprasidona
HN2001000072A (es) Contenedor
HN1998000199A (es) Agentes terapeuticos
PA8543701A1 (es) Fenil-heterociclil-eteres
HN1998000045A (es) Composiciones farmaceuticas
HN2000000219A (es) Compuesto farmaceuticamente activos
HN2000000188U (es) Arado combinado
HN2000000083A (es) Complejo farmaceutico
FR2817648B1 (fr) Reflecteur sonore actif
HN1999000202A (es) Derivados de higromicina
HN2000000276A (es) Derivados de tiazolilamida
HN2000000242A (es) Derivados de higromicina
HN2000000064A (es) Compuestos quimicos
HN2000000062A (es) Compuestos de benzolactama sustituidos
HN2001200100A (es) Derivados de eteres de pirazol como agentes antinflamatorios analgesicos.
HN1999000181A (es) Formulaciones antiparasitarias.
HN2001000135A (es) Derivados de purina
HN1998000072A (es) Tetrazoles
HN2000000191A (es) Los inhibidores triciclicos de poli (adp-ribosa)
HN1999000205A (es) Formulaciones antiparasitos
HN1999000171A (es) Concentrado oral de sertralina.
HN1998000134A (es) Fungicidas
HN2000000205A (es) Derivados de purina